Submitted:
26 February 2024
Posted:
26 February 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design, Participants and Patients
- -
- 30-days mortality after hospital admission in patients with AMI;
- -
- proportion of PTCA (Percutaneous Transluminal Coronary Angioplasty) performed in STEMI (ST-Elevation Myocardial Infarction) patients within 90 minutes from the access to the hospital Emergency Room (ER);
- -
- in-hospital mortality in patients with ischemic stroke;
- -
- proportion of hospital readmissions within 30-days from the discharge in patients with ischemic stroke;
2.2. A&F Intervention and Control Group
2.3. Data Sources
2.4. Variables in Analysis
2.5. Data Management and Statistical Analysis
3. Results
3.1. Participating Hospitals
3.2. Patients’ Populations
3.2.1. AMI Patient’s Cohort
3.2.2. STEMI Patient’s Cohort
3.2.3. Ischemic Stroke Patient’s Cohort
3.3. Intervention Effectiveness Evaluation
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Programma Nazionale Esiti – Edition 2021. Available at: https://www.agenas.gov.it/comunicazione/primo-piano/2005-pne-2021-agenas-presenta-i-risultati-al-ministero-della-salute. (accessed on 10 September 2022). (accessed on 10 September 2022).
- P.Re.Val.E. (Programma Regionale Valutazione Esiti”—Regional Program for Outcomes and Processes Evaluation) edition 2022 and 2023 web sites. Available at: https://www.dep.lazio.it/prevale2022/ ; https://www.dep.lazio.it/prevale2023/. (accessed on 15 September 2022). (accessed on 15 September 2022).
- Ivers, N.; Jamtvedt, G.; Flottorp, S.; Young, J.M.; Odgaard-Jensen, J.; French, S.D.; O’Brien, M.A.; Johansen, M.; Grimshaw, J.; Oxman, A.D. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database of Syst. Rev. 2012, 6, 1465–1858. [Google Scholar] [CrossRef] [PubMed]
- Desveaux, L.; Ivers, N.M.; Devotta, K.; Ramji, N.; Weyman, K.; Kiran T. Unpacking the intention to action gap: a qualitative study understanding how physicians engage with audit and feedback. Implement. Sci. 2021, 16(1):19. [CrossRef]
- Moore, L.; Guertin, J.R.; Tardif, P.A.; Ivers, N.M.; Hoch, J.; Conombo, B.; Antony, J.; Stelfox, H.T.; Berthelot, S.; Archambault, P.; Turgeon, A.; Gandhi, R.; Grimshaw, J.M. Economic evaluations of audit and feedback interventions: a systematic review. BMJ Qual. Saf. 2022, 31(10), 754–767. [Google Scholar] [CrossRef] [PubMed]
- Schondelmeyer, A.C.; Bettencourt, A.P.; Xiao, R.; Beidas, R.S.; Wolk, C.B.; Landrigan, C.P.; Brady, P.W.; Brent, C,R,; Parthasarathy, P.; Kern-Goldberger, A.S.; Sergay, N.; Lee, V.; Russell, C.J.; Prasto, J.; Zaman, S.; McQuistion, K.; Lucey, K.; Solomon, C.; Garcia, M.; Bonafide, C.P. Pediatric Research in Inpatient Settings (PRIS) Network. Evaluation of an Educational Outreach and Audit and Feedback Program to Reduce Continuous Pulse Oximetry Use in Hospitalized Infants With Stable Bronchiolitis: A Nonrandomized Clinical Trial. JAMA Netw Open. 2021 Sep 1, 4(9): e2122826. [CrossRef]
- Goulao, B.; Scott, C.; Black, I.; Clarkson, J.; McArthur, L.; Ramsay, C.; Young, L.; Duncan, E. Audit and feedback with or without training in-practice targeting antibiotic prescribing (TiPTAP): a study protocol of a cluster randomised trial in dental primary care. Implement Sci. 2021 Mar 30;16(1):32. [CrossRef]
- Lau, R.; Stevenson, F.; Ong, B.N.; Dziedzic, K.; Treweek, S.; Eldridge, S.; Everitt, H.; Kennedy, A.; Qureshi, N.; Rogers, A.; Peacock, R.; Murray, E. Achieving change in primary care-effectiveness of strategies for improving implementation of complex interventions: systematic review of reviews. BMJ Open. 2015 Dec 23, 5(12):e009993. [CrossRef]
- Tuti, T.; Nzinga, J.; Njoroge, M.; Brown, B.; Peek, N.; English, M.; Paton, C.; van der Veer, S.N. A systematic review of electronic audit and feedback: intervention effectiveness and use of behaviour change theory. Implement Sci. 2017 May 12,12(1):61. 12 May. [CrossRef]
- Chatzopoulou, M.; Kyriakaki A.; Reynolds L. Review of antimicrobial resistance control strategies: low impact of prospective audit with feedback on bacterial antibiotic resistance within hospital settings. Infect. Dis. (Lond) 2021, 53(3), 159- 68. [CrossRef]
- Ivers, N.M.; Grimshaw, J.M.; Jamtvedt, G.; Flottorp, S.; O’Brien, M.A.; French, S.D.; Young, J.; Odgaard-Jensen, J. Growing literature, stagnant Science? Systematic review, meta-regression and cumulative analysis of audit and feedback interventions in health care. J. Gen. Intern. Med. 2014, 29, 1534–1541. [Google Scholar] [CrossRef]
- Grimshaw, J.M.; Ivers, N.; Linklater, S.; Foy, R.; Francis, J.J.; Gude, W.T.; Hysong, S.J. Reinvigorating stagnant science: implementation laboratories and a meta-laboratory to efficiently advance the science of audit and feedback. BMJ Qual. Saf. 2019, 28(5), 416–23. [Google Scholar] [CrossRef] [PubMed]
- Foy R.; Skrypak M.; Alderson S.; Ivers N.M.; McInerney B.; Stoddart J.; Ingham J.; Keenan D. Revitalising audit and feedback to improve patient care. BMJ 2020, 368:m213. [CrossRef]
- Brehaut, J.C.; Colquhoun, H.L.; Eva, K.W.; Carroll, K.; Sales, A.; Michie, S.; Ivers, N.; Grimshaw, J.M. Practice feedback interventions: 15 suggestions for optimizing effectiveness. Ann. Intern. Med. 2016, 164, 435–441. [Google Scholar] [CrossRef]
- Willis TA, Hartley S, Glidewell L, Farrin AJ, Lawton R, McEachan RRC, et al. Action to Support Practices Implement Research Evidence (ASPIRE): protocol for a cluster-randomised evaluation of adaptable implementation packages targeting ‘high impact’ clinical practice recommendations in general practice. Implement Sci. 29 febbraio 2016;11:25.
- Foster, M.; Presseau, J.; Podolsky, E.; McIntyre, L.; Papoulias, M.; Brehaut, J.C. How well do critical care audit and feedback interventions adhere to best practice? Development and application of the REFLECT-52 evaluation tool. Implement. Sci. 2021, 16(1), 81. [Google Scholar] [CrossRef] [PubMed]
- Angelici, L.; Angioletti, C.; Pinnarelli, L.; Colais, P.; de Mattia, E.; Agabiti, N.; Davoli, M.; Acampora A. EASY-NET Program: Methods and Preliminary Results of an Audit and Feedback Intervention in the Emergency Care for Acute Myocardial Infarction in the Lazio Region, Italy. Healthcare (Basel). 2023 Jun 5;11(11):1651. [CrossRef]
- EASY-NET Project Web Site. Available online: https://easy-net.info/ (accessed on 15 July 2022).
- Colquhoun, H.L.; Carroll, K.; Eva, K.W.; Grimshaw, G.M.; Ivers, N.; Michie, S.; Sales, A.; Brehaut, J.C. Advancing the literature on designing audit and feedback interventions: Identifying theory-informed hypotheses. Implement. Sci. 2017, 12, 117. [Google Scholar] [CrossRef] [PubMed]
- Bourrée, F.; Michel, P.; Salmi, L.R. Méthodes de consensus: Revue des méthodes originales et de leurs grandes variantes utilisées en santé publique [Consensus methods: Review of original methods and their main alternatives used in public health]. Rev. Epidemiol. Sante Publique 2008, 56, 415–423. [Google Scholar] [CrossRef] [PubMed]
- Laforgia, P.L.; Auguadro, C.; Bronzato, S.; Durante, A. The reduction of mortality in acute myocardial infarction: From bed rest to future directions. Int. J. Prev. Med. 2022, 13, 56. [Google Scholar].
- P.Re.Val.E Edition 2022 Web Site. Volume of Hospitalization for AMI from 2012 to 2021. Available online: https://www.dep.lazio.it/prevale2022/risultati/tipo5/home_tipo5.php?ind=122&tipo=5&area=1 (accessed on 15 September 2022).
- Angelici, L.; Sorge, C.; Di Martino, M.; Cappai, G.; Stafoggia, M.; Agabiti, N.; Girardi, E.; Lanini, S.; Nicastri, E.; Davoli, M.; Cesaroni. G. Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome. J Clin Med. 2022, 7;11(3):877. /: https. [CrossRef]
- Rete emergenza ospedaliera – Afferenze rete emergenza ospedaliera adulti. https://www.regione.lazio.it/enti/salute/sistemi-emergenza/rete-emergenza-ospedaliera (accessed on 15 September 2023).
- Rete ICTUS. https://www.regione.lazio.it/enti/salute/sistemi-emergenza/rete-ictus- (accessed on 15 September 2023).
- Amato, L.; Fusco, D.; Acampora, A.; Bontempi, K.; Rosa, A.C.; Colais, P.; Cruciani, F.; D'Ovidio, M.; Mataloni, F., Minozzi, S.; Mitrova, Z.; Pinnarelli, L.; Saulle, R., Soldati, S.; Sorge, C.; Vecchi, S.; Ventura, M.; Davoli, M. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data. Epidemiol Prev. 2017, 41(5-6 (Suppl 2)):1-128. [CrossRef]
- Programmazione della rete ospedaliera 2021-2023 in conformità agli standard previsti nel DM 70/2015 https://www.regione.lazio.it/sites/default/files/documentazione/SAL_DD_G01328_10_02_2022_Allegato_1.pdf (accessed Dec. 28, 2023).
- P.Re.Val.E. (Programma Regionale Valutazione Esiti” - Regional Program for Outcomes and Processes Evaluation- Strumenti per Audit) edition 2022 and 2023 web sites. Available at: https://www.dep.lazio.it/prevale2022/audit/audit_qualita1.php?ind=1;https://www.dep.lazio.it/prevale2023/audit/audit_qualita1.php?ind=1.(accessed on 16 September 2023).
- The BC Emergency Medicine Network: Evaluation approach and early findings. British Columbia Medical Journal. https://bcmj.org/articles/bc-emergency-medicine-network-evaluation-approach-and-early-findings (accessed Dec. 27, 2023).
- Evans, J.M.; Commisso, E.; Grudniewicz A.; Im, J.; Veillard, J.; Richards, G. Managing the performance of healthcare networks: a ‘dance’ between control and collaboration. Public Manag. Rev. 2023. /: https. [CrossRef]
- Vola, F.; Benedetto, V.; Vainieri M.; Nuti S. The Italian interregional performance evaluation system. Res. Heal. Serv. Reg. 2022, 11, 1(1): 1–14. [CrossRef]
- Il sistema di monitoraggio. https://www.salute.gov.it/portale/lea/dettaglioContenutiLea.jsp?lingua=italiano&id=4744&area=Lea&menu=monitoraggioLea (accessed Dec. 28, 2023).


| 30-days mortality after first hospital admission in patients with AMI | χ2 p-value | |||||
|---|---|---|---|---|---|---|
| Yes | No | Total | ||||
| N | row% | N | row% | N | ||
| Total | 839 | 11357 | 12196 | |||
| A&F intervention | 0.011 | |||||
| Exposed | 517 | 7.4 | 6485 | 92.6 | 7002 | |
| Control | 322 | 6.2 | 4872 | 93.8 | 5194 | |
| Year | 0.842 | |||||
| 2021 | 409 | 6.8 | 5577 | 93.2 | 5986 | |
| 2022 | 430 | 6.9 | 5780 | 93.1 | 6210 | |
| Sex | <.0001 | |||||
| Female | 354 | 9.8 | 3251 | 90.2 | 3605 | |
| Male | 485 | 5.6 | 8106 | 94.4 | 8591 | |
| Age (years) | <.0001 | |||||
| 19-59 | 60 | 1.9 | 3033 | 98.1 | 3093 | |
| 60-69 | 92 | 3.0 | 2976 | 97.0 | 3068 | |
| 70-79 | 220 | 7.3 | 2795 | 92.7 | 3015 | |
| 80-100 | 467 | 15.5 | 2553 | 84.5 | 3020 | |
| Education level | <.0001 | |||||
| Degree | 69 | 5.5 | 1175 | 94.5 | 1244 | |
| Lower middle high school | 215 | 5.4 | 3731 | 94.6 | 3946 | |
| Middle high school | 176 | 5.1 | 3292 | 94.9 | 3468 | |
| None or elementary | 340 | 11.2 | 2692 | 88.8 | 3032 | |
| Not stated | 39 | 7.7 | 467 | 92.3 | 506 | |
| Concomitant clinical conditions | ||||||
| Cancer | 97 | 14.4 | 577 | 85.6 | 674 | <.0001 |
| Diabetes | 89 | 12.3 | 633 | 87.7 | 722 | <.0001 |
| Lipid metabolism disorders | 25 | 7.1 | 329 | 92.9 | 354 | 0.890 |
| Obesity | 5 | 7.6 | 61 | 92.4 | 66 | 0.823 |
| Obesity at index admission | 13 | 2.4 | 525 | 97.6 | 538 | <.0001 |
| Anaemias | 62 | 19.0 | 264 | 81.0 | 326 | <.0001 |
| Anaemias at index admission | 54 | 9.7 | 504 | 90.3 | 558 | 0.008 |
| Coagulation defects | 1 | 16.7 | 5 | 83.3 | 6 | 0.343 |
| Coagulation defects at index admission | _ | _ | 3 | 100.0 | 3 | 0.638 |
| Other haematological diseases | 2 | 6.5 | 29 | 93.5 | 31 | 0.925 |
| Other haematological diseases at index admission | 4 | 8.7 | 42 | 91.3 | 46 | 0.626 |
| Arterial hypertension | 112 | 9.1 | 1125 | 90.9 | 1237 | 0.001 |
| Previous myocardial infarction | 54 | 5.7 | 895 | 94.3 | 949 | 0.132 |
| Other forms of ischemic heart disease | 90 | 9.0 | 905 | 91.0 | 995 | 0.005 |
| Heart failure | 90 | 16.6 | 452 | 83.4 | 542 | <.0001 |
| Not well-defined forms and complications of heart disease | 6 | 8.0 | 69 | 92.0 | 75 | 0.701 |
| Rheumatic heart disease | 6 | 14.0 | 37 | 86.0 | 43 | 0.066 |
| Rheumatic heart disease at index admission | 27 | 16.9 | 133 | 83.1 | 160 | <.0001 |
| Cardiomyopathies | 8 | 14.5 | 47 | 85.5 | 55 | 0.024 |
| Cardiomyopathies at index admission | 8 | 5.8 | 131 | 94.2 | 139 | 0.599 |
| Acute endocarditis and myocarditis | _ | _ | 6 | 100.0 | 6 | 0.506 |
| Other cardiac conditions | 14 | 13.3 | 91 | 86.7 | 105 | 0.009 |
| Other cardiac conditions at index admission | 35 | 10.8 | 289 | 89.2 | 324 | 0.005 |
| Conduction disorders and arrhythmias | 75 | 13.1 | 499 | 86.9 | 574 | <.0001 |
| Cerebrovascular diseases | 47 | 11.4 | 366 | 88.6 | 413 | 0.000 |
| Cerebrovascular diseases at index admission | 34 | 10.2 | 300 | 89.8 | 334 | 0.016 |
| Vascular diseases | 40 | 13.3 | 260 | 86.7 | 300 | <.0001 |
| Vascular diseases at index admission | 24 | 6.5 | 348 | 93.5 | 372 | 0.741 |
| Chronic obstructive pulmonary disease (COPD) | 38 | 13.2 | 249 | 86.8 | 287 | <.0001 |
| Chronic nephropathy | 68 | 15.7 | 364 | 84.3 | 432 | <.0001 |
| Chronic kidney disease | 116 | 10.9 | 945 | 89.1 | 1061 | <.0001 |
| Chronic diseases (liver, pancreas, intestines) | 9 | 13.2 | 59 | 86.8 | 68 | 0.038 |
| Chronic diseases (liver, pancreas, intestine) at index admission | 7 | 10.0 | 63 | 90.0 | 70 | 0.301 |
| Previous coronary artery bypass grafting | 31 | 9.7 | 287 | 90.3 | 318 | 0.041 |
| Previous coronary angioplasty | 65 | 5.3 | 1168 | 94.7 | 1233 | 0.019 |
| Cerebrovascular revascularization | 6 | 7.9 | 70 | 92.1 | 76 | 0.726 |
| Other heart surgery | 13 | 17.6 | 61 | 82.4 | 74 | 0.000 |
| Other vessel surgery | 30 | 11.4 | 233 | 88.6 | 263 | 0.003 |
| Type of hospital* | 0.120 | |||||
| EADI | 554 | 6.8 | 7575 | 93.2 | 8129 | |
| EADII | 262 | 7.3 | 3327 | 92.7 | 3589 | |
| ER | 23 | 4.8 | 455 | 95.2 | 478 | |
| % PTCA STEMI patients within 90 min of admission to the ER | χ2 p-value | |||||
|---|---|---|---|---|---|---|
| Yes | No | Total | ||||
| N | row% | N | row% | N | ||
| Total | 3077 | 2007 | 5084 | |||
| A&F intervention | 0.069 | |||||
| Exposed | 1950 | 59.6 | 1322 | 40.4 | 3272 | |
| Control | 1127 | 62.2 | 685 | 37.8 | 1812 | |
| Year | 0.003 | |||||
| 2021 | 1420 | 58.4 | 1013 | 41.6 | 2433 | |
| 2022 | 1657 | 62.5 | 994 | 37.5 | 2651 | |
| Sex | <.0001 | |||||
| Female | 701 | 54.5 | 586 | 45.5 | 1287 | |
| Male | 2376 | 62.6 | 1421 | 37.4 | 3797 | |
| Age (years) | <.0001 | |||||
| 21-57 | 879 | 67.3 | 428 | 32.7 | 1307 | |
| 58-65 | 808 | 66.5 | 407 | 33.5 | 1215 | |
| 66-75 | 781 | 60.1 | 519 | 39.9 | 1300 | |
| 76-100 | 609 | 48.3 | 653 | 51.7 | 1262 | |
| Education level | <.0001 | |||||
| Degree | 339 | 58.8 | 238 | 41.2 | 577 | |
| Lower middle high school | 1031 | 62.2 | 626 | 37.8 | 1657 | |
| Middle high school | 988 | 63.0 | 581 | 37.0 | 1569 | |
| None or elementary | 548 | 54.0 | 467 | 46.0 | 1015 | |
| Not stated | 171 | 64.3 | 95 | 35.7 | 266 | |
| Concomitant clinical conditions | ||||||
| Cancer | 109 | 44.9 | 134 | 55.1 | 243 | <.0001 |
| Diabetes | 67 | 41.6 | 94 | 58.4 | 161 | <.0001 |
| Lipid metabolism disorders | 36 | 45.0 | 44 | 55.0 | 80 | 0.004 |
| Obesity | 7 | 43.8 | 9 | 56.3 | 16 | 0.169 |
| Obesity at index admission | 126 | 56.8 | 96 | 43.2 | 222 | 0.240 |
| Anaemias | 16 | 26.7 | 44 | 73.3 | 60 | <.0001 |
| Anaemias at index admission | 60 | 37.7 | 99 | 62.3 | 159 | <.0001 |
| Coagulation defects | 1 | 100.0 | _ | _ | 1 | 0.419 |
| Coagulation defects at index admission | 1 | 100.0 | _ | _ | 1 | 0.419 |
| Other haematological diseases | 5 | 33.3 | 10 | 66.7 | 15 | 0.031 |
| Other haematological diseases at index admission | 11 | 64.7 | 6 | 35.3 | 17 | 0.724 |
| Arterial hypertension | 166 | 51.1 | 159 | 48.9 | 325 | 0.000 |
| Previous myocardial infarction | 81 | 38.4 | 130 | 61.6 | 211 | <.0001 |
| Other forms of ischemic heart disease | 96 | 44.2 | 121 | 55.8 | 217 | <.0001 |
| Heart failure | 27 | 32.5 | 56 | 67.5 | 83 | <.0001 |
| Not well-defined forms and complications of heart disease | 4 | 30.8 | 9 | 69.2 | 13 | 0.028 |
| Rheumatic heart disease | 4 | 50.0 | 4 | 50.0 | 8 | 0.542 |
| Rheumatic heart disease at index admission | 18 | 41.9 | 25 | 58.1 | 43 | 0.012 |
| Cardiomyopathies | 3 | 18.8 | 13 | 81.3 | 16 | 0.001 |
| Cardiomyopathies at index admission | 23 | 39.7 | 35 | 60.3 | 58 | 0.001 |
| Acute endocarditis and myocarditis | _ | _ | 1 | 100.0 | 1 | 0.216 |
| Other cardiac conditions | 2 | 15.4 | 11 | 84.6 | 13 | 0.001 |
| Other cardiac conditions at index admission | 21 | 31.8 | 45 | 68.2 | 66 | <.0001 |
| Conduction disorders and arrhythmias | 45 | 36.9 | 77 | 63.1 | 122 | <.0001 |
| Cerebrovascular diseases | 54 | 45.0 | 66 | 55.0 | 120 | 0.000 |
| Cerebrovascular diseases at index admission | 42 | 34.4 | 80 | 65.6 | 122 | <.0001 |
| Vascular diseases | 28 | 35.0 | 52 | 65.0 | 80 | <.0001 |
| Vascular diseases at index admission | 42 | 39.6 | 64 | 60.4 | 106 | <.0001 |
| Chronic obstructive pulmonary disease (COPD) | 23 | 38.3 | 37 | 61.7 | 60 | 0.000 |
| Chronic nephropathy | 37 | 38.1 | 60 | 61.9 | 97 | <.0001 |
| Chronic kidney disease | 131 | 44.3 | 165 | 55.7 | 296 | <.0001 |
| Chronic diseases (liver, pancreas, intestines) | 9 | 47.4 | 10 | 52.6 | 19 | 0.240 |
| Chronic diseases (liver, pancreas, intestine) at index admission | 13 | 48.1 | 14 | 51.9 | 27 | 0.187 |
| Previous coronary artery bypass grafting | 19 | 41.3 | 27 | 58.7 | 46 | 0.007 |
| Previous coronary angioplasty | 159 | 50.6 | 155 | 49.4 | 314 | 0.000 |
| Cerebrovascular revascularization | 10 | 62.5 | 6 | 37.5 | 16 | 0.871 |
| Other heart surgery | 6 | 28.6 | 15 | 71.4 | 21 | 0.003 |
| Other vessel surgery | 25 | 37.9 | 41 | 62.1 | 66 | 0.000 |
| Type of hospital* | 0.142 | |||||
| EADI | 1909 | 61.3 | 1204 | 38.7 | 3113 | |
| EADII | 1168 | 59.3 | 803 | 40.7 | 1971 | |
| In hospital 30-days mortality after admission in patients with ischemic stroke | χ2 p-value | |||||
|---|---|---|---|---|---|---|
| Yes | No | Total | ||||
| N | row% | N | row% | N | ||
| Total | 432 | 5517 | 5949 | |||
| A&F intervention | 0.006 | |||||
| Exposed | 249 | 8.2 | 2803 | 91.8 | 3052 | |
| Control | 183 | 6.3 | 2714 | 93.7 | 2897 | |
| Year | 0.081 | |||||
| 2021 | 232 | 7.9 | 2722 | 92.1 | 2954 | |
| 2022 | 200 | 6.7 | 2795 | 93.3 | 2995 | |
| Sex | <.0001 | |||||
| Female | 243 | 8.8 | 2512 | 91.2 | 2755 | |
| Male | 189 | 5.9 | 3005 | 94.1 | 3194 | |
| Age (years) | <.0001 | |||||
| 35-66 | 26 | 1.7 | 1482 | 98.3 | 1508 | |
| 67-76 | 71 | 4.8 | 1401 | 95.2 | 1472 | |
| 77-83 | 111 | 7.8 | 1318 | 92.2 | 1429 | |
| 84-100 | 224 | 14.5 | 1316 | 85.5 | 1540 | |
| Education level | <.0001 | |||||
| Degree | 24 | 4.2 | 543 | 95.8 | 567 | |
| Lower middle high school | 107 | 6.7 | 1492 | 93.3 | 1599 | |
| Middle high school | 76 | 5.5 | 1304 | 94.5 | 1380 | |
| None or elementary | 211 | 10.0 | 1901 | 90.0 | 2112 | |
| Not stated | 14 | 4.8 | 277 | 95.2 | 291 | |
| Concomitant clinical conditions | ||||||
| Cancer | 21 | 9.9 | 192 | 90.1 | 213 | 0.137 |
| Diabetes | 34 | 11.8 | 254 | 88.2 | 288 | 0.002 |
| Lipid metabolism disorders | 7 | 6.4 | 103 | 93.6 | 110 | 0.714 |
| Obesity | 4 | 11.1 | 32 | 88.9 | 36 | 0.372 |
| Obesity at index admission | 9 | 6.5 | 130 | 93.5 | 139 | 0.718 |
| Anaemias | 23 | 13.5 | 147 | 86.5 | 170 | 0.001 |
| Anaemias at index admission | 11 | 6.1 | 169 | 93.9 | 180 | 0.546 |
| Coagulation defects | _ | _ | 3 | 100.0 | 3 | 0.628 |
| Coagulation defects at index admission | 1 | 8.3 | 11 | 91.7 | 12 | 0.886 |
| Other haematological diseases | 1 | 6.7 | 14 | 93.3 | 15 | 0.929 |
| Other haematological diseases at index admission | 4 | 9.3 | 39 | 90.7 | 43 | 0.605 |
| Arterial hypertension | 71 | 12.0 | 520 | 88.0 | 591 | <.0001 |
| Previous myocardial infarction | 14 | 11.1 | 112 | 88.9 | 126 | 0.092 |
| Other forms of ischemic heart disease | 27 | 10.7 | 226 | 89.3 | 253 | 0.033 |
| Heart failure | 50 | 17.4 | 237 | 82.6 | 287 | <.0001 |
| Not well-defined forms and complications of heart disease | 4 | 9.8 | 37 | 90.2 | 41 | 0.537 |
| Rheumatic heart disease | 8 | 17.8 | 37 | 82.2 | 45 | 0.006 |
| Rheumatic heart disease at index admission | 2 | 3.3 | 58 | 96.7 | 60 | 0.239 |
| Cardiomyopathies | 3 | 10.0 | 27 | 90.0 | 30 | 0.562 |
| Cardiomyopathies at index admission | 3 | 8.3 | 33 | 91.7 | 36 | 0.804 |
| Acute endocarditis and myocarditis | _ | _ | 3 | 100.0 | 3 | 0.628 |
| Other cardiac conditions | 12 | 14.6 | 70 | 85.4 | 82 | 0.010 |
| Other cardiac conditions at index admission | 8 | 3.5 | 220 | 96.5 | 228 | 0.026 |
| Conduction disorders and arrhythmias | 55 | 14.6 | 321 | 85.4 | 376 | <.0001 |
| Cerebrovascular diseases | 40 | 9.6 | 378 | 90.4 | 418 | 0.059 |
| Vascular diseases | 11 | 8.0 | 126 | 92.0 | 137 | 0.726 |
| Vascular diseases at index admission | 15 | 6.0 | 233 | 94.0 | 248 | 0.452 |
| Chronic obstructive pulmonary disease (COPD) | 21 | 16.9 | 103 | 83.1 | 124 | <.0001 |
| Chronic nephropathy | 26 | 16.4 | 133 | 83.6 | 159 | <.0001 |
| Chronic nephropathy at index admission | 29 | 13.2 | 191 | 86.8 | 220 | 0.001 |
| Chronic kidney disease | 3 | 8.6 | 32 | 91.4 | 35 | 0.765 |
| Diseases chronic diseases (liver, pancreas, intestine) | 2 | 4.8 | 40 | 95.2 | 42 | 0.531 |
| Diseases chronic diseases (liver, pancreas, intestine) at index admission | 9 | 6.3 | 135 | 93.8 | 144 | 0.636 |
| Cerebrovascular revascularization | _ | _ | 27 | 100.0 | 27 | 0.145 |
| Other heart surgery | 13 | 19.4 | 54 | 80.6 | 67 | <.0001 |
| Other vessel surgery | 11 | 8.5 | 119 | 91.5 | 130 | 0.594 |
| Type of hospital* | 0.207 | |||||
| noNVT | 15 | 12.0 | 110 | 88.0 | 125 | |
| NVT | 11 | 6.3 | 164 | 93.7 | 175 | |
| NTUI | 209 | 7.1 | 2742 | 92.9 | 2951 | |
| NTUII | 197 | 7.3 | 2501 | 92.7 | 2698 | |
| % of in hospital readmissions within 30-days of discharge for ischemic stroke | χ2 p-value | |||||
|---|---|---|---|---|---|---|
| Yes | No | Total | ||||
| N | row% | N | row% | N | ||
| Total | 392 | 5061 | 5453 | |||
| A&F intervention | 0.910 | |||||
| Exposed | 201 | 7.8 | 2580 | 92.8 | 2781 | |
| Control | 191 | 7.7 | 2481 | 92.9 | 2672 | |
| Year | 0.248 | |||||
| 2021 | 182 | 7.3 | 2503 | 93.2 | 2685 | |
| 2022 | 210 | 8.2 | 2558 | 92.4 | 2768 | |
| Sex | 0.062 | |||||
| Female | 159 | 6.9 | 2321 | 93.6 | 2480 | |
| Male | 233 | 8.5 | 2740 | 92.2 | 2973 | |
| Age (years) | 0.005 | |||||
| 35-66 | 71 | 5.5 | 1296 | 94.8 | 1367 | |
| 67-76 | 101 | 8.1 | 1240 | 92.5 | 1341 | |
| 77-83 | 125 | 9.4 | 1323 | 91.4 | 1448 | |
| 84-100 | 95 | 7.9 | 1202 | 92.7 | 1297 | |
| Education level | 0.432 | |||||
| Degree | 41 | 8.2 | 498 | 92.4 | 539 | |
| Lower middle high school | 96 | 6.9 | 1384 | 93.5 | 1480 | |
| Middle high school | 90 | 7.5 | 1202 | 93.0 | 1292 | |
| None or elementary | 149 | 8.7 | 1719 | 92.0 | 1868 | |
| Not stated | 16 | 6.2 | 258 | 94.2 | 274 | |
| Concomitant clinical conditions | ||||||
| Cancer | 16 | 9.1 | 175 | 91.6 | 191 | 0.518 |
| Diabetes | 18 | 7.8 | 232 | 92.8 | 250 | 0.994 |
| Lipid metabolism disorders | 7 | 7.5 | 93 | 93.0 | 100 | 0.941 |
| Obesity | 4 | 14.3 | 28 | 87.5 | 32 | 0.243 |
| Obesity at index admission | 4 | 3.2 | 125 | 96.9 | 129 | 0.069 |
| Anaemias | 12 | 9.0 | 133 | 91.7 | 145 | 0.608 |
| Anaemias at index admission | 12 | 8.1 | 149 | 92.5 | 161 | 0.895 |
| Coagulation defects | 1 | 50.0 | 2 | 66.7 | 3 | 0.080 |
| Coagulation defects at index admission | 1 | 11.1 | 9 | 90.0 | 10 | 0.731 |
| Other haematological diseases | 1 | 7.7 | 13 | 92.9 | 14 | 0.995 |
| Other haematological diseases at index admission | 2 | 5.6 | 36 | 94.7 | 38 | 0.645 |
| Arterial hypertension | 35 | 7.3 | 481 | 93.2 | 516 | 0.708 |
| Previous myocardial infarction | 7 | 6.7 | 104 | 93.7 | 111 | 0.716 |
| Other forms of ischemic heart disease | 17 | 8.3 | 205 | 92.3 | 222 | 0.782 |
| Heart failure | 27 | 13.0 | 207 | 88.5 | 234 | 0.009 |
| Not well-defined forms and complications of heart disease | 4 | 12.1 | 33 | 89.2 | 37 | 0.392 |
| Rheumatic heart disease | 5 | 16.1 | 31 | 86.1 | 36 | 0.118 |
| Rheumatic heart disease at index admission | 10 | 21.3 | 47 | 82.5 | 57 | 0.002 |
| Cardiomyopathies | 1 | 3.8 | 26 | 96.3 | 27 | 0.482 |
| Cardiomyopathies at index admission | 3 | 10.0 | 30 | 90.9 | 33 | 0.671 |
| Acute endocarditis and myocarditis | _ | _ | 3 | 100.0 | 3 | 0.630 |
| Other cardiac conditions | 8 | 13.3 | 60 | 88.2 | 68 | 0.142 |
| Other cardiac conditions at index admission | 16 | 7.9 | 203 | 92.7 | 219 | 0.945 |
| Conduction disorders and arrhythmias | 30 | 10.5 | 286 | 90.5 | 316 | 0.102 |
| Cerebrovascular diseases | 32 | 9.4 | 340 | 91.4 | 372 | 0.274 |
| Vascular diseases | 11 | 9.6 | 114 | 91.2 | 125 | 0.481 |
| Vascular diseases at index admission | 11 | 5.0 | 221 | 95.3 | 232 | 0.140 |
| Chronic obstructive pulmonary disease (COPD) | 10 | 10.8 | 93 | 90.3 | 103 | 0.318 |
| Chronic nephropathy | 18 | 15.9 | 113 | 86.3 | 131 | 0.003 |
| Chronic nephropathy at index admission | 23 | 13.9 | 166 | 87.8 | 189 | 0.007 |
| Chronic kidney disease | 6 | 23.1 | 26 | 81.3 | 32 | 0.011 |
| Diseases chronic diseases (liver, pancreas, intestine) | 3 | 8.3 | 36 | 92.3 | 39 | 0.903 |
| Diseases chronic diseases (liver, pancreas, intestine) at index admission | 9 | 7.3 | 123 | 93.2 | 132 | 0.868 |
| Cerebrovascular revascularization | _ | _ | 27 | 100.0 | 27 | 0.147 |
| Other heart surgery | 7 | 15.2 | 46 | 86.8 | 53 | 0.088 |
| Other vessel surgery | 11 | 10.5 | 105 | 90.5 | 116 | 0.334 |
| Type of hospital* | 0.551 | |||||
| noNVT | 8 | 7.8 | 102 | 92.7 | 110 | |
| NVT | 16 | 11.0 | 146 | 90.1 | 162 | |
| NTUI | 197 | 7.9 | 2506 | 92.7 | 2703 | |
| NTUII | 171 | 7.4 | 2307 | 93.1 | 2478 | |
| AMI/STEMI PATHWAY | ||||||
|---|---|---|---|---|---|---|
| INDICATORS | Facilities (patients) | 30-days mortality after first hospital admission in patients with AMI | Facilities(patients) | % PTCA STEMI patients within 90 min of admission to the ER | ||
| Unadjusted | Adjusted* | Unadjusted | Adjusted** | |||
| EXPOSED | ||||||
| Pre-2021 (%) | 12 (3393) | 7.40 | 10.51 | 12 (1541) | 58.66 | 58.12 |
| Post-2022 (%) | 15 (3609) | 7.37 | 10.29 | 12 (1731) | 60.43 | 59.43 |
| Difference Post/Pre (pp) | -0.03 | -0.22 | 1.77 | 1.31 | ||
| CONTROL | ||||||
| Pre-2021 (%) | 15 (2593) | 6.09 | 9.48 | 8 (892) | 57.85 | 56.79 |
| Post-2022 (%) | 16 (2601) | 6.31 | 9.34 | 8 (920) | 66.41 | 65.42 |
| Difference Post/Pre (pp) | 0.22 | -0.14 | 8.56 | 8.63 | ||
| DID pp | -0.24 | -0.08 | -6.80 | -7.29 | ||
| (95%CI) | (-2.03; 1.56) | (-2.80; 2.65) | (- 12.38; -1.22) | (-12.75; -1.83) | ||
| p-value for interaction | 0.794 | 0.956 | 0.017 | 0.009 | ||
| ISCHEMIC STROKE PATHWAY | ||||||
|---|---|---|---|---|---|---|
| INDICATORS | Facilities(patients) | In hospital 30-days mortality after admission in patients with ischemic stroke | Facilities(patients) | % of in-hospital readmissions within 30-days of discharge for ischemic stroke | ||
| Unadjusted | Adjusted* | Unadjusted | Adjusted | |||
| EXPOSED | ||||||
| Pre-2021 (%) | 8 (1885) | 8.54 | 7.89 | 8 (1711) | 7.36 | 7.33 |
| Post-2022 (%) | 8 (1908) | 6.87 | 7.15 | 8 (1760) | 6.88 | 6.79 |
| Difference Post/Pre (pp) | -1.67 | -0.74 | -0.48 | -0.54 | ||
| CONTROL | ||||||
| Pre-2021 (%) | 8 (1069) | 6.64 | 6.65 | 8 (974) | 5.75 | 5.51 |
| Post-2022 (%) | 9 (1087) | 6.35 | 6.91 | 9 (1008) | 8.83 | 8.76 |
| Difference Post/Pre (pp) | -0.29 | 0.26 | 3.08 | 3.25 | ||
| DID pp | -1.38 | -0.99 | -3.57 | -3.80 | ||
| (95%CI) | (-4.07; 1.30) | (-2.93; 0.95) | (-6.42; -0.72) | (-6.57; -1.03) | ||
| p-value for interaction | 0.313 | 0.315 | 0.014 | 0.007 | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).